Amgen (AMGN) Receivables (2009 - 2026)
Amgen (AMGN) recorded Receivables of $10.23 billion in Q2 2026, up 17.5% from $8.7 billion a year earlier and up 11.9% from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) Receivables (2009 - 2026) Analysis & Trends
At the end of FY2025, Amgen reported Receivables of $9.57 billion, up 41.1% from FY2024.
- Annual Receivables has a five-year compound annual growth rate of 16.2% (FY2020 to FY2025).
- Across earlier years, Receivables came in at $6.78 billion in FY2024 (-6.7%), $7.27 billion in FY2023 (+30.6%), $5.56 billion in FY2022 (+13.6%) and $4.9 billion in FY2021 (+8.2%).
- The Q2 2026 figure is the highest quarterly Receivables in data going back to Q2 2009.
- On a year-over-year basis, Receivables has increased for six consecutive quarters, with growth averaging 18.1% over the last eight quarters.
- Peak year-over-year performance for Receivables in the last five years was growth of 41.1% in Q4 2025, against a decline of 6.7% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $9.14 billion (Q1 2026), $9.57 billion (Q4 2025) and $8.49 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 10.66 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.23 Bn |
| Mar 31, 2026 | 9.14 Bn |
| Dec 31, 2025 | 9.57 Bn |
| Sep 30, 2025 | 8.49 Bn |
| Jun 30, 2025 | 8.70 Bn |
| Mar 31, 2025 | 8.13 Bn |
| Dec 31, 2024 | 6.78 Bn |
| Sep 30, 2024 | 7.32 Bn |
| Jun 30, 2024 | 6.93 Bn |
| Mar 31, 2024 | 6.78 Bn |
| Dec 31, 2023 | 7.27 Bn |
| Sep 30, 2023 | 6.15 Bn |
| Jun 30, 2023 | 5.83 Bn |
| Mar 31, 2023 | 5.74 Bn |
| Dec 31, 2022 | 5.56 Bn |
| Sep 30, 2022 | 5.33 Bn |
| Jun 30, 2022 | 5.33 Bn |
| Mar 31, 2022 | 5.08 Bn |
| Dec 31, 2021 | 4.90 Bn |
| Sep 30, 2021 | 4.77 Bn |
API Access
Amgen Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();